Track record
Investment, defense, enterprise transformation, brand alignment, and institutional foresight. Each result below carries a real number and a one-line method note — what we measured and how.
CrowdSmart-guided investment decisions produced nearly twice the survival rate of comparable funds across an eight-year deployment. CrowdSmart-evaluated startups survived at 71% against a 38% Carta 2018 cohort baseline.
In 2017, CrowdSmart's collective evaluation scored Syntiant at 93% pROI — years before the market caught up. Today Syntiant has deployed 100M+ edge AI processors across four continents and is approaching a $1B valuation ahead of a planned 2027 IPO.
A diverse ensemble of document-grounded Knowledge Agents forecasted FDA approval of orforglipron (Foundayo) for obesity/overweight — and got it right when the decision resolved in April 2026. Every probability, citation, and disagreement stayed inspectable: accurate enough to compete with established prediction markets, transparent enough to trust.
Synthesized collective intelligence across dozens of acquired companies to align leadership on post-M&A integration strategy — surfacing shared priorities that no single executive team could have identified alone. Decision cycles went from weeks to hours. 500+ executives used CrowdSmart across HR, sales, and C-suite as Alera became the 12th-largest US independent insurance firm.
Deployed the platform during a brand refresh to rapidly align stakeholders on a new strategic vision — the kind of transformational moment where internal alignment is the bottleneck.
Diverse perspectives were synthesized into an actionable shared vision — the kind of envisioning work that traditionally collapses past a dozen participants.
Consistent across categories
Orchestrated 30+ evaluators simultaneously. Identity-blind peer review eliminated politics. Bayesian belief networks surfaced non-obvious risk.
Corpus-grounded Knowledge Agents deliberated with full provenance — citations, confidence, and disagreement preserved — then calibrated against a resolved FDA outcome.
Unlimited participants, zero pre-training. Anonymous contributions created candor. Persistent models of institutional thinking evolved over time.